Tag Archives: cancer research

Research on Polar Organisms May Shed New Light on Effective Cancer Treatment

New Research on Polar Organisms
New Research on Polar Organisms

Cryobiology is the study of how low temperatures affect living things. It has been around for thousands of years and lead to many life-saving procedures like cryopreservation of organs at low temperatures for transplant. Immunotherapy has been around for over one hundred years and is used by Issels® immuno-oncology to successfully treat many types of cancer. While transplant organs are stored at cool temperatures, blood, semen and many thin tissues can be maintained practically indefinitely via liquid nitrogen cryopreservation at sub-freezing temperatures. Many living organisms can survive long periods below freezing.

Understanding how some micro-organisms are thriving in the harsh Polar Regions may help researchers develop new cancer treatment techniques.

Arctic study of bacteria may provide new cancer treatments

Shiv Mohan Singh is a cryobiologist and senior researcher with Goa’s National Center for Antarctic and Ocean Research. As a member of India’s first expedition to the Arctic back in 2007, Singh has been studying how some organisms develop survival mechanisms to endure the harsh climate.

They have found that bacteria in Arctic glaciers survive by producing anti-freeze proteins, opening up possible applications in the cryopreservation of blood and organs. One substance that is of particular interest is thelebolan, a derivative from an Antarctic fungus, which has been shown to stall tumor cell growth and induce cell death in cancer lines.

When modern insights and innovations are applied to sciences that have been around for many years, incredible advancements are made in medical treatments. Issels® immuno-oncology uses highly personalized immunotherapy and other non-toxic alternative treatments for cancer. Visit our news blog for the latest advancements in cancer research and contact us to learn more about our integrative immunotherapy treatments.

Why Is It Taking So Long to Find a Cure for Cancer?

Ideas on finding a cure for cancer.
Ideas on finding a cure for cancer.

At Issels®, we know that many of our readers wonder about research being done to find a cure for cancer. Many impatiently wait for progress as cancer leaves an indelible mark on anyone who has ever had cancer or known and/or loved someone who has had cancer.

Why is a cure taking so long?

Scientists are still trying to understand all of the complex processes that turn cells into the many types of cancers that exist.

How Does Cancer Form?

As Dr. Craig Thompson, CEO of the Memorial Sloan Kettering Cancer Center, pointed out in a recent article about this topic, family genetic inheritance, the formation site, immune system responses and cellular changes all factor into the complex puzzle that is cancer. We know that the last two items have the most influence:

  • The immune system isn’t perfect. Severe allergies and asthma are conditions that often happen when the immune system becomes confused about what it should or should not fight off to protect the body. Cancer is another example.
  • Many cells mutate into cancer because of natural aging changes we don’t yet completely understand. Sometimes there are errors during growth that repeat when new cells form. Lastly, cells can experience DNA damage from microorganisms, radiation, toxins and poor habits like smoking and tanning.

As Thompson noted, the key is to understand the “biology of cancer” and then use that knowledge to prevent it in those who don’t have it and create new treatments that precisely deal with causation in those who do.

At Issels® Immuno-Oncology, we have integrated many of the most recent precision techniques into our non-toxic, customized cancer treatment plans. For more information, contact us today.

Popular Men’s Supplements Tied to Testicular Cancer

Illustration depicting a screen shot of an internet search bar containing a cancer treatment concept.
Popular Men’s Supplements Tied to Testicular Cancer

Men who try to improve their bodies using muscle-building supplements may ultimately cause the opposite effect. Research shows that the consumption of popular supplements like creatine and androstenedione can increase the risk of testicular cancer.

A team of scientists at Yale University conducted a series of interviews with more than 900 men regarding their workout programs and history of supplement use. They were also asked to give details of smoking and drinking habits, family history of testicular cancer and their own incidents of groin injury. More than 350 of the respondents had been previously diagnosed with testicular germ cell cancer.

Data indicated that weekly supplement use for a minimum of four consecutive weeks resulted in a 65 percent greater likelihood of having received a diagnosis of testicular cancer. Use of more than one supplement raised the risk of developing testicular cancer by 177 percent, while use for three or more years resulted in a 156 percent increase.

According to study leader Tongzhang Zheng, risks were increased by factors such as use at a younger age, use over a longer time period, and use of multiple supplements. While the study confirms the correlation between supplement use and testicular cancer, it will take more research to determine if there is an actual cause-and-effect relationship and if so, what drives it.

At Issels®, we also conduct a careful analysis of your personal lifestyle, environment and genetic background in order to develop a cancer treatment program that addresses your specific needs. Visit our website to learn more about our non-toxic integrative immuno-oncology protocols. 


Bayer Give $1 Million to Aid in Cancer Information Technology Platform

Stack of Money
Big Donations

Here at Issels® whenever we hear a great piece of cancer news, we’re always excited to share it. According to a recent news article, Bayer HealthCare, one of the giants in the world of healthcare, has contributed one million dollars toward funding for CancerLinQ.

Advances in technology have paved the way for improved cancer treatments in recent years, and CancerLinQ is no exception. Experts believe that this technological platforms is going to be very instrumental in unlocking information about patients who are living with cancer. This information can then be used to alter the quality of care cancer patients receive, as well as work towards developing more personalized treatments for them.

Once data has been captured from current cancer patients, as well as from their caregivers, CancerLinQ goes to work on their individual needs and experiences. This is a revolutionary concept that has the ability to improve care for everyone who is affected by a cancer diagnosis.

Bayer Healthcare has been committed to cancer research for years. Their oncology franchise includes three products and many compounds that are currently being developed. It is exciting to see that they have partnered with the Conquer Cancer Foundation and the American Society of Clinical Oncology, and it will be even more exciting to see how CancerLinQ changes the quality of care for cancer patients in the years ahead.

A cancer diagnosis can change so many parts of your life, but your road to remission doesn’t have to be paved with uncertainty and pain. Here at Issels®, we view cancer treatment and patients very differently. We would love to talk to you about alternative treatment options. Please contact us.

Team Finds New Treatment for Acute Myeloid Leukaemia (AML)

Cancer Research
Cancer Research Finds New Treatment for Blood Cancer

Australian researchers have found that a drug called Imetelstat has the potential to fight and sometimes defeat blood cancer. Following the recent trials in Brisbane, the FDA has recently cleared the way for clinical trials in the United States.

How Does Imetelstat Kill Cancer Cells?

The medication works by manipulating a particular protein of the blood. Imetelstat effectively “turns off” a certain gene to prevent the formation of a protein called telomerase. Without that protein, the stem cells that become leukemia cells cannot be formed. Existing cancer cells begin to disappear.

The news is especially exciting because chemotherapy has its lowest success rates with acute myeloid leukemia, or AML.

Patients who have undergone unsuccessful chemotherapy for AML can potentially use Imetelstat to prolong life or possibly enter remission. For all AML patients, Imetelstat could be used as a follow-up treatment after chemotherapy to help prevent the cancer from returning.

What’s Next for Blood Cancer Medicine?

After the Australian team recently published their findings and made a presentation to the American Society of Hematology, interest in the treatment has further increased.

The FDA had previously been concerned by a possible connection between Imetelstat and liver problems, but that issue has been ruled out. With that hurdle cleared, optimism is building for the breakthrough drug to succeed in human trials and find approval for all patients with AML.

Many alternative treatments are currently available for patients with cancer resistant to standard therapies. Contact Issels® Integrative Immuno-Oncology for information about our innovative cancer treatments.

Will Your Low Fat Diet Help You Beat Breast Cancer?

Woman with Basket of Food
A Low Fat Diet May Help You Beat Breast Cancer.

A study by Dr. Rowan Chlebowski, a medical oncologist at Harbor-UCLA Medical Center’s Los Angeles Biomedical Research Institute, shows that some women diagnosed with breast cancer who maintain a low-fat diet may reduce their risk of early death.

Research for women in the early stages of breast cancer specific to estrogen receptor-negative (ER-negative) cancer showed positive results. For this group, Dr. Chlebowski’s study showed a reduced risk of death factor of 36 percent over a 15-year study for patients who maintained a diet of low-fat food for five years after being diagnosed.

For women diagnosed with both ER-negative and progesterone-receptor negative (PR-negative) cancer, the results were even higher. Following the same five year low-fat diet regimen after initial diagnosis, patients experienced a 56 percent reduction in risk of death due to any cause.

The study included over 2,400 women ranging in age from 48 to 79 in the early stages of breast cancer. Of the 2,400 women, approximately 1,600 were diagnosed with ER-positive cancer while the remaining 800 were diagnosed with ER-negative or both ER and PR-negative cancer.

During the study, low-fat diets for half of the women was a requirement. Unannounced checks were made throughout the study. The other group was not required to maintain a low-fat diet. The study showed a lower death rate in the low-fat diet research group.

The study is the first where a low-fat diet over an extended period for cancer patients has been researched.

For information about how integrative immuno-oncology works in the treatment of breast cancer, contact Issels®. Established in 1951, Issels® has made a name for itself internationally for its success in the long-term remission of advanced tumors.